Terms: = Cervical cancer AND TPR, P12270, 7175 AND Treatment
4 results:
1. Dosimetric and feasibility evaluation of a CBCT-based daily adaptive radiotherapy protocol for locally advanced cervical cancer.
Branco D; Mayadev J; Moore K; Ray X
J Appl Clin Med Phys; 2023 Jan; 24(1):e13783. PubMed ID: 36208134
[TBL] [Abstract] [Full Text] [Related]
2. Consensus and recommendations on vaginal-cuff Brachytherapy of the Spanish Brachytherapy Groups of SEOR and SEFM.
Samper Ots PM; Rovirosa Casino A; Herreros Martínez A; Rodriguez Villalba S; Pérez Calatayud J; Polo Cezón R; Gutiérrez Miguélez C; Anchuelo Latorre J; Rodríguez Rodríguez I; Córdoba Largo S; Pérez Echagüen S; Sanz Freire CJ; Clemente Gutiérrez F; De Las Peñas Cabrera D; Villafranca Iturre E;
Clin Transl Oncol; 2021 Jun; 23(6):1193-1200. PubMed ID: 33237447
[TBL] [Abstract] [Full Text] [Related]
3. A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery.
Pu J; Qin SS; Ding JX; Zhang Y; Zhu WG; Yu CH; Li T; Tao GZ; Ji FZ; Zhou XL; Han JH; Ji YL; Sun JX
J Cancer Res Clin Oncol; 2013 Apr; 139(4):703-8. PubMed ID: 23328996
[TBL] [Abstract] [Full Text] [Related]
4. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
[TBL] [Abstract] [Full Text] [Related]
